IL-23 antagonists
US8227579B2 · kind B2 · utility
8Cited by
16References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 27, 2010 |
| Grant date | Jul 24, 2012 |
| Priority date | — |
| Expiry date | Aug 27, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to blocking, inhibiting, reducing, antagonizing or neutralizing the activity of IL-17, IL-23 via it's p19 subunit or both IL-17 and IL-23 (via p19). IL-17 and IL-23 are cytokines that are involved in inflammatory processes and human disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.